Concepedia

Keyvan Mahboubi

KM

Statistics

Publications

17

Citations

1.5K

H-Index

15

Active since

1992

Affiliations

Yale University(Current)

New York Medical College

Institute for Diabetes Discovery

Inserm

Ionis Pharmaceuticals (United States)

Keyvan Mahboubi is an author at Yale University specializing in life sciences, signal transduction, and pharmacology.

Publications per year

1992–2019

17

Publications

17

Angiopoietin-1 Inhibits Endothelial Cell Apoptosis via the Akt/Survivin Pathway

Andreas Papapetropoulos, David Fulton, Keyvan Mahboubi et al. · Journal of Biological Chemistry · 2000 · 634 citations · Full text

, , +17

Cytochrome P450‐dependent effects of bradykinin in the rat heart

David Fulton, Keyvan Mahboubi, J C McGiff et al. · British Journal of Pharmacology · 1995 · 118 citations · Full text

, , +15

Interleukin-11 Up-Regulates Survivin Expression in Endothelial Cells through a Signal Transducer and Activator of Transcription-3 Pathway

Keyvan Mahboubi, Fengzhi Li, Janet Plescia et al. · Laboratory Investigation · 2001 · 113 citations · Full text

, , +15

Cyclooxygenase-2 Is Required for Tumor Necrosis Factor-α– and Angiotensin II–Mediated Proliferation of Vascular Smooth Muscle Cells

W. Glenn Young, Keyvan Mahboubi, Asifa Haider et al. · Circulation Research · 2000 · 85 citations · Full text

, , +11

Interleukin-11 and Interleukin-6 Protect Cultured Human Endothelial Cells from H2O2-Induced Cell Death

Aaron B. Waxman, Keyvan Mahboubi, R. G. Knickelbein et al. · American Journal of Respiratory Cell and Molecular Biology · 2003 · 85 citations

, , +12

1–5 of 17